| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |